ANIKAnika Therapeutics, Inc.

$213M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$120M-0.7% YoY

Gross Profit

$76M63.4% margin

Operating Income

-$5M-4.3% margin

Net Income

-$56M-47.0% margin

EPS (Diluted)

$-3.83

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

-$2M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$203M

Total Liabilities

$49M

Stockholders' Equity

$154M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$120M	$121M	-0.7%
Gross Profit	$76M	$83M	-7.9%
Operating Income	-$5M	$844,000	-704.4%
Net Income	-$56M	-$83M	+31.8%

ANIK FY 2024 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena